Infectious agents are not necessary for murine atherogenesis.
about
Gut flora metabolism of phosphatidylcholine promotes cardiovascular diseaseRole of Nucleotide-binding and Oligomerization Domain 2 Protein (NOD2) in the Development of AtherosclerosisS100A8 and S100A9 in cardiovascular biology and diseaseCholesterol crystals and inflammationHuman Microbiome: When a Friend Becomes an EnemyInflammasomes and metabolic disorders: old genes in modern diseasesDrivers of age-related inflammation and strategies for healthspan extensionTherapeutic targeting of NOD1 receptorsNLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystalsVascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studiesThe quantity of nitric oxide released by macrophages regulates Chlamydia-induced disease.Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences.The gut microbiota, environment and diseases of modern society.Role of toll-like receptor 4 in intimal foam cell accumulation in apolipoprotein E-deficient miceAtherosclerosis and Alzheimer--diseases with a common cause? Inflammation, oxysterols, vasculatureNLRP3 inflammasomes link inflammation and metabolic disease.Toll-like receptor 4 and atherogenesis.Helicobacter pylori vs coronary heart disease - searching for connections.Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injuryUnraveling the environmental and genetic interactions in atherosclerosis: Central role of the gut microbiota.Immunomodulation and vaccination for atherosclerosis.Cholesterol, Inflammasomes, and Atherogenesis.Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease.Linking immune-mediated arterial inflammation and cholesterol-induced atherosclerosis in a transgenic mouse model.Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophagesAtherosclerosis and innate immune signaling.Intestinal Immunity and Gut Microbiota in Atherogenesis.Protective role for TLR4 signaling in atherosclerosis progression as revealed by infection with a common oral pathogen.Development potential of rifalazil and other benzoxazinorifamycins.Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein EEmerging role of Toll-like receptors in atherosclerosis.The role of innate immunity in atherogenesis.Lipopolysaccharide, CD14 and Toll-like receptors: an emerging link between innate immunity and atherosclerotic disease.The role of gut microbiota (commensal bacteria) and the mucosal barrier in the pathogenesis of inflammatory and autoimmune diseases and cancer: contribution of germ-free and gnotobiotic animal models of human diseases.Toll-like receptor signaling: common pathways that drive cardiovascular disease and rheumatoid arthritis.Molecular biology of atherosclerosis.Processes of sterile inflammation.Inflammasome activation by nucleic acids and nucleosomes in sterile inflammation… or is it sterile?The immunology of atherosclerosis.
P2860
Q24601951-341EEB55-45E5-4F5D-8405-0B55B1BD342AQ26777991-21AD39AD-2009-4420-B5B3-DF6014E2D37CQ27024450-61537B02-67C1-4FC1-AAA1-3E4BF73679C9Q27024737-E6F3ADB8-1E2A-4BE0-9340-4D5C92E2DC94Q28085629-A945D00B-CB0B-4883-BDEA-787A353FFFBDQ28389531-BAAD7329-D11F-4D3F-ABE7-94EF0E1B8EC2Q28649560-273CB140-99A9-47B2-9879-DA6BF36886C9Q28676201-9237D7B3-124A-486F-A410-E17655DE33D2Q29615704-89DCD1EA-EACC-4164-BE7A-672E84072082Q30319434-0505F9FB-03AB-4DF2-9B01-86F1A31790C1Q33905858-FB29DF33-4184-42E9-9AF3-AE5B39E098B8Q34021196-0FFE0EFF-1ADC-42C0-89D4-993C8F6DB113Q34324267-FAA6D96C-66DD-47BD-86F4-7B55F73EFF8DQ34348985-67974723-72C1-44F2-AFD1-CFE830E297B0Q34555906-ACA640E9-F471-4183-A7A4-D5198328C992Q35127516-4829EDF4-DA10-4342-949C-4C7C9B5FDBDBQ35151726-EF28C001-81CB-47D8-A567-5D1E5600275EQ35160975-D36C62D6-5BCB-4259-A3D0-82CB0FD1F70CQ35501136-415EF68B-C0BE-47AE-A39D-DDA4974448D7Q35540926-E11B3888-E18B-49F6-AB04-CD7C7D64608BQ35662826-AFAE4093-CCE6-4697-AC5F-58A4F9EECA8DQ35753555-0357C17D-F409-4084-AA1F-7A9DB39A009BQ35773615-F9CC6B96-5415-487E-8B08-9EBCBA0E3151Q35775318-504E0AB3-EEF6-4E83-84E8-0C4C1B1A62DDQ35824235-967ADF13-53A2-457D-8A8A-AAA915F43433Q36084261-16B13262-E086-4C42-800F-8E4231B153A6Q36198508-29C968F6-E907-4AAF-AF74-9E3996AFFABBQ36215494-D65A33F1-5843-4556-8295-B8BA3086D384Q36252511-FEC4627A-793E-4518-A313-8D0636B44E7EQ36491823-21BF4B2D-A31A-47C7-BD98-984FA8E4FAC7Q36986664-33047D86-15C7-4238-AC8F-76A31970D556Q37316197-9350D513-C08F-4A25-9D4D-CFDB169CE1ADQ37357462-5B63C4A8-5F0A-45FF-88F2-781772E70BEEQ37608487-D50C00DA-97B8-4A8B-A6E2-E297217786ABQ37729525-389F92F1-4888-4204-ABD6-495B1983DBC1Q37859678-09CC3C20-C6E6-44CE-9F6A-D51E270E2A29Q38125279-100FF23A-A140-4F00-AC3E-67BC7AD06ACBQ38135408-35A15FA1-D029-43DF-98C2-181836CCD3EFQ38735363-6C97AD0B-F509-4A0E-9EDF-8E0A58AEAC01Q39230390-80B92C96-19AB-4C13-A9B1-9D919A72AED1
P2860
Infectious agents are not necessary for murine atherogenesis.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
Infectious agents are not necessary for murine atherogenesis.
@ast
Infectious agents are not necessary for murine atherogenesis.
@en
type
label
Infectious agents are not necessary for murine atherogenesis.
@ast
Infectious agents are not necessary for murine atherogenesis.
@en
prefLabel
Infectious agents are not necessary for murine atherogenesis.
@ast
Infectious agents are not necessary for murine atherogenesis.
@en
P2093
P2860
P356
P1476
Infectious agents are not necessary for murine atherogenesis.
@en
P2093
A Hermanowski-Vosatka
C P Sparrow
J D Bergstrom
J Montenegro
M Hernandez
P A Detmers
S D Wright
P2860
P304
P356
10.1084/JEM.191.8.1437
P407
P577
2000-04-01T00:00:00Z